Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication in connection with the 30th Annual General Meeting of the Company
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals Limited has submitted copies of newspaper publications confirming the dispatch of the Notice for its 30th Annual General Meeting along with the Annual Report for FY 2024-2025. The notice was published in Business Standard (English) and Makkal Kural (Tamil) on Wednesday, August 27, 2025. The filing has been made to BSE and NSE under Regulation 30 of SEBI (LODR) Regulations, 2015. The company's registered office is in Chennai, and the communication was signed by Mohanachandran A, Company Secretary & Compliance Officer. This is a standard regulatory compliance disclosure required before a company's AGM.
This is a routine regulatory filing and does not have any direct impact on the stock price or shareholder value. It simply confirms that shareholders have been formally notified about the upcoming 30th AGM and have access to the annual report for FY 2024-2025.